Eli Lilly to Buy Skin-Drug Maker Dermira for $1.1 Billion

(Bloomberg) -- Eli Lilly & Co. agreed to acquire Dermira Inc. for $1.1 billion, snapping up the maker of an experimental treatment for skin disorder dermatitis that was recently placed on a fast tr...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.